GLP1 medications do more than support weight lossthey can play a meaningful role in heart health, blood sugar control and even sleep quality
August 1, 2025: Mounjaro Demand Is Unsustainable in UK, According to Health Officials The National Pharmacy Association cautions that the demand for weight loss injections (like Mounjaro) is unsustainable in the United Kingdom
The dual mechanism offers a promising advantage over traditional GLP-1 RAs such as semaglutide , which is found in diabetes and weight management medications such as Ozempic and Wegovy
However, the disadvantages include the possibility of regaining lost weight, incomplete reversal of aesthetic changes, and, in cases requiring corrective procedures, high costs, invasiveness, and longer recovery times
Botulinum toxin and cosmetic fillers for under 18s guidance for enforcement officers